Tanaka, Yoshiya https://orcid.org/0000-0002-0807-7139
Article History
Accepted: 3 February 2025
First Online: 22 February 2025
Declarations
:
: There was no funding for preparing the manuscript.
: YT has received speaking fees and/or honoraria from Abbvie, Eisai, Chugai, Eli-Lilly, Behringer-Ingelheim, GlaxoSmithKline, Taisho, AstraZeneca, Daiichi-Sankyo, Gilead, Pfizer, UCB, Asahi-kasei, Astellas, received research grants from Behringer-Ingelheim, Taisho, Chugai. However, they are not relevant to preparation of the article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Substantial contributions to review conception, interpretation of reviewed literature, drafting the article, revising it critically for important intellectual content, and final approval of the version of the article to be published: YT.